Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
Pharmacology, Toxicology and Pharmaceutical Science
29
7%
Agricultural and Biological Sciences
25
6%
Biochemistry, Genetics and Molecular Biology
11
3%
Nursing and Health Professions
7
2%
Other
38
10%
Unknown
103
26%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 49. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2026.
All research outputs
#1,080,935
of 34,205,147 outputs
Outputs from Diabetologia
#544
of 6,884 outputs
Outputs of similar age
#2,979
of 174,384 outputs
Outputs of similar age from Diabetologia
#4
of 53 outputs
Altmetric has tracked 34,205,147 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,884 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.5. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,384 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.
